EUR 0.36
(-2.72%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | -1.08 Million EUR | -137.58% |
2022 | 2.87 Million EUR | 1357.52% |
2021 | 197 Thousand EUR | -58.87% |
2020 | 479 Thousand EUR | -4.96% |
2019 | 504 Thousand EUR | -88.89% |
2018 | 4.53 Million EUR | -4.23% |
2017 | 4.73 Million EUR | -1.6% |
2016 | 4.81 Million EUR | 24.58% |
2015 | 3.86 Million EUR | 27.85% |
2014 | 3.02 Million EUR | 24.48% |
2013 | 2.42 Million EUR | 30.38% |
2012 | 1.86 Million EUR | -2.66% |
2011 | 1.91 Million EUR | 27.27% |
2010 | 1.5 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | -8000.00 EUR | 0.0% |
2023 Q2 | 557 Thousand EUR | 0.0% |
2023 Q4 | 4.05 Million EUR | 0.0% |
2023 FY | -1.07 Million EUR | -137.58% |
2022 Q2 | 91.07 Thousand EUR | 0.0% |
2022 FY | 2.87 Million EUR | 1357.52% |
2022 Q4 | 388.68 Thousand EUR | 0.0% |
2021 FY | 197 Thousand EUR | -58.87% |
2021 Q2 | 38.64 Thousand EUR | 0.0% |
2021 Q4 | 102 Thousand EUR | 0.0% |
2020 Q2 | 100 Thousand EUR | 0.0% |
2020 Q4 | 379 Thousand EUR | 0.0% |
2020 FY | 479 Thousand EUR | -4.96% |
2019 Q2 | 179 Thousand EUR | 0.0% |
2019 Q4 | 325 Thousand EUR | 0.0% |
2019 FY | 504 Thousand EUR | -88.89% |
2018 Q4 | 2 Million EUR | 0.0% |
2018 Q2 | 2.52 Million EUR | 0.0% |
2018 FY | 4.53 Million EUR | -4.23% |
2017 Q2 | 2.26 Million EUR | 0.0% |
2017 Q4 | 2.47 Million EUR | 0.0% |
2017 FY | 4.73 Million EUR | -1.6% |
2016 Q4 | 2.43 Million EUR | 0.0% |
2016 FY | 4.81 Million EUR | 24.58% |
2016 Q2 | 2.37 Million EUR | 0.0% |
2015 Q2 | 1.77 Million EUR | 0.0% |
2015 Q4 | 2.08 Million EUR | 0.0% |
2015 FY | 3.86 Million EUR | 27.85% |
2014 FY | 3.02 Million EUR | 24.48% |
2014 Q4 | 1.51 Million EUR | 0.0% |
2014 Q2 | 1.5 Million EUR | 0.0% |
2013 Q3 | 18.28 Thousand EUR | -98.42% |
2013 Q4 | 1.09 Million EUR | 5871.72% |
2013 FY | 2.42 Million EUR | 30.38% |
2013 Q2 | 1.15 Million EUR | 0.0% |
2012 FY | 1.86 Million EUR | -2.66% |
2012 Q4 | 18.28 Thousand EUR | 52.83% |
2012 Q1 | 11.96 Thousand EUR | 0.0% |
2012 Q2 | 11.96 Thousand EUR | 0.0% |
2012 Q3 | 11.96 Thousand EUR | 0.0% |
2011 Q3 | 11.62 Thousand EUR | 0.0% |
2011 FY | 1.91 Million EUR | 27.27% |
2011 Q1 | 11.62 Thousand EUR | 0.0% |
2011 Q2 | 11.62 Thousand EUR | 0.0% |
2011 Q4 | 11.96 Thousand EUR | 2.9% |
2010 Q3 | 8747.50 EUR | 0.0% |
2010 Q2 | 8747.50 EUR | 0.0% |
2010 Q1 | 8747.50 EUR | 0.0% |
2010 FY | 1.5 Million EUR | 0.0% |
2010 Q4 | 11.62 Thousand EUR | 32.9% |
2009 Q4 | 8747.50 EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | 109.105% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | 9544.75% |
Carmat SA | 21.54 Million EUR | 105.014% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | 105.966% |
Euromedis Groupe | 17.6 Million EUR | 106.135% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 102.282% |
Ikonisys S.A. | 2.44 Million EUR | 144.105% |
Implanet S.A. | 9.29 Million EUR | 111.628% |
Median Technologies SA | 46.34 Million EUR | 102.331% |
SpineGuard SA | 7.35 Million EUR | 114.689% |
Euroapi S.A. | 398.9 Million EUR | 100.271% |
Guerbet SA | 550.79 Million EUR | 100.196% |
Ion Beam Applications SA | 128.02 Million EUR | 100.844% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 100.018% |
Sequana Medical NV | 30.03 Million EUR | 103.597% |